Last year we announced the launch of The Rosenman Institute, a medical technology partnership between California Institute of Quantitative Bioscience (QB3), the UCSF Department of Surgery, the UCSF Department of Bioengineering and Therapeutic Sciences (BTS), and Friends of Dan Rosenman. The institute is named for the late Daniel Casper Rosenman, who dedicated 25 years to the field of medical devices. According to Kaspar Mossman, QB3’s Director of Communications and Marketing, over the past year, the Rosenman Institute has processed more than 20 proposals from entrepreneurs and matched them with Rosenman Fellows who act as mentors to the development projects. Specifically, two start-ups have successfully launched from the Institute focusing on cardiology and orthopedics.
Each year, the Institute plans to hold a symposium targeted at building a Bay Area ecosystem for aspiring entrepreneurs in the medical device field who want to make connections and form partnerships. Last year’s symposium launch saw the largest ever attended QB3 event, with this year’s event already exceeding last year’s attendance by more than 200 people.
The main focus of this year’s half day symposium will be “precision medicine”, which is a major initiative at UCSF and since there is a lot of momentum in this area, the Rosenman Institute selected this topic to maintain alignment with the objectives of its parent institution. Presenters this year include Illumina, Heartflow, Organovo, UCSF, and a panel discussion comprised of investors and industry experts. The Institute will also recognize recipients of the Rosenman Innovation Awards, presented to two teams to aid in the acceleration of their concepts.
You can register for this free event here…
“How Precision Medicine is Transforming Medical Devices”: the 2nd Annual Rosenman Institute Symposium
Byers Auditorium, UCSF Mission Bay
Wednesday, June 24, 2015 from 1:00 PM to 5:30 PM (PDT)
San Francisco, CA